Vaccine Prevents Growth of Colorectal Tumors Related to Lynch Syndrome in Mice
Friday, April 19, 2019
Steven Lipkin, M.D., Ph.D., Co-Leader of the Meyer Cancer Center's Cancer Genetics, Epigenetics, and Systems Biology Program, reported results of a cancer prevention vaccine at the American Association for Cancer Research 2019 Annual Meeting. The vaccine prevented the growth of colorectal tumors in a mouse model of Lynch syndrome and prolonged the mice’s survival compared with unvaccinated mice.
“The simplicity of this approach means that it is promising to take forward” to a human vaccine, Dr. Lipkin said during a press briefing April 1 at the AACR's annual meeting in Atlanta. Read more about the exciting results of this study funded by the National Cancer Institute on their Cancer Currents Blog.